Boston Scientific Announces Schedule for Heart Rhythm Society Scientific Sessions Boston Scientific Corporation (NYSE: BSX) announces its schedule of major events and sponsored research at Heart Rhythm 2012, the Heart Rhythm...

NATICK, Mass. , May 3, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) announces its schedule of major events and sponsored research at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, which takes place May 9 – 12 in Boston . The scheduled clinical presentations will provide new insights for physicians who treat patients with heart disorders including sudden cardiac arrest, atrial fibrillation and heart failure.

Schedule of Events All times are EDT, with events to be held at the Boston Convention Center unless otherwise indicated.

Tuesday, May 8 (Pre-Conference)

Wednesday, May 9

Thursday, May 10

Conference attendees are invited to view Boston Scientific's latest cardiac rhythm management and electrophysiology products at booth #1033 in the main exhibit hall.

About Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com .

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, scientific activities, product performance, competitive offerings and our business plans. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

SOURCE Boston Scientific Corporation